These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30467191)

  • 1. Functional cardiac orexin receptors: role of orexin-B/orexin 2 receptor in myocardial protection.
    Patel VH; Karteris E; Chen J; Kyrou I; Mattu HS; Dimitriadis GK; Rodrigo G; Antoniades C; Antonopoulos A; Tan BK; Hillhouse EW; Ng A; Randeva HS
    Clin Sci (Lond); 2018 Dec; 132(24):2547-2564. PubMed ID: 30467191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Orexin-B/Orexin 2 receptor in myocardial protection.
    Imperatore R; Cristino L
    Clin Sci (Lond); 2019 Apr; 133(7):853-857. PubMed ID: 30948623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
    Salie R; Alsalhin AKH; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G; Arnoletti E; Bassino E; Penna C; Perrelli MG; Ghé C; Muccioli G
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H470-81. PubMed ID: 20525876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selenoprotein T-derived peptide protects the heart against ischaemia/reperfusion injury through inhibition of apoptosis and oxidative stress.
    Rocca C; Boukhzar L; Granieri MC; Alsharif I; Mazza R; Lefranc B; Tota B; Leprince J; Cerra MC; Anouar Y; Angelone T
    Acta Physiol (Oxf); 2018 Aug; 223(4):e13067. PubMed ID: 29575758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
    Kaur K; Singh N; Dhawan RK
    Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
    Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
    Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
    García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
    Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
    Qian W; Zhao C; Li D; Dai R
    Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin Protects Against Myocardial Ischemia/Reperfusion Injury via Activation of RISK (Reperfusion Injury Salvage Kinase) and SAFE (Survivor Activating Factor Enhancement) Pathways.
    Yang X; Yue R; Zhang J; Zhang X; Liu Y; Chen C; Wang X; Luo H; Wang WE; Chen X; Wang HJ; Jose PA; Wang H; Zeng C
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart.
    Duan Q; Xu Y; Marck PV; Kalisz J; Morgan EE; Pierre SV
    J Cardiovasc Pharmacol; 2018 Feb; 71(2):95-103. PubMed ID: 29419572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
    Ansari M; Kurian GA
    Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.